USA - NASDAQ:ARAY - US0043971052 - Common Stock
Overall ARAY gets a fundamental rating of 2 out of 10. We evaluated ARAY against 190 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ARAY have multiple concerns. While showing a medium growth rate, ARAY is valued expensive at the moment.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -0.34% | ||
ROE | -1.96% | ||
ROIC | 2.23% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 1.71% | ||
PM (TTM) | N/A | ||
GM | 32.05% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.53 | ||
Debt/FCF | N/A | ||
Altman-Z | 0.08 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.65 | ||
Quick Ratio | 0.92 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | 18.63 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:ARAY (10/22/2025, 2:32:36 PM)
1.565
-0.05 (-2.8%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 0.38 | ||
P/FCF | N/A | ||
P/OCF | 61.68 | ||
P/B | 2.17 | ||
P/tB | 22.79 | ||
EV/EBITDA | 18.63 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -0.34% | ||
ROE | -1.96% | ||
ROCE | 2.82% | ||
ROIC | 2.23% | ||
ROICexc | 2.81% | ||
ROICexgc | 4.22% | ||
OM | 1.71% | ||
PM (TTM) | N/A | ||
GM | 32.05% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.53 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | 8.85 | ||
Cap/Depr | 69.46% | ||
Cap/Sales | 0.93% | ||
Interest Coverage | 0.81 | ||
Cash Conversion | 20.44% | ||
Profit Quality | N/A | ||
Current Ratio | 1.65 | ||
Quick Ratio | 0.92 | ||
Altman-Z | 0.08 |